Cargando…
Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?
Autor principal: | Eun, Lucy Youngmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351277/ https://www.ncbi.nlm.nih.gov/pubmed/30693682 http://dx.doi.org/10.4070/kcj.2018.0460 |
Ejemplares similares
-
Is multisystem inflammatory syndrome related with coronavirus disease 2019, Kawasaki disease, and angiotensin-converting enzyme 2 in children?
por: Eun, Lucy Youngmin
Publicado: (2021) -
Infliximab Treatment for Refractory Kawasaki Disease in Korean Children
por: Song, Min Seob, et al.
Publicado: (2010) -
Infliximab as rescue therapy in refractory Kawasaki disease
por: Rodríguez-González, Moisés, et al.
Publicado: (2014) -
Iron deficiency anemia as a predictor of coronary artery abnormalities in Kawasaki disease
por: Kim, Sohyun, et al.
Publicado: (2019) -
New Horizons
por: Dogra, Vikram
Publicado: (2011)